Unknown PHASE1 INTERVENTIONAL 1-arm NCT04415346

A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Sponsor: Huons Co., Ltd.

Conditions Post Stroke Upper Limb Spasticity

Interventions HU-014 Inj

Updated 6 times since 2020 Last updated: May 31, 2020 Started: Nov 6, 2019 Primary completion: Jun 30, 2020 Completion: Oct 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Post Stroke Upper Limb Spasticity and is currently ongoing. Huons Co., Ltd. leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Enrolling By Invitation → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Enrolling By Invitation PHASE1

▶ Show 1 earlier version

Jul 2020 — Jan 2021 [monthly]

Enrolling By Invitation PHASE1

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huons Co., Ltd.

Data source: Huons Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea